GlassScriptPhysician profile
Talal Faris
NPI 1598767634
$26,042.77
in general payments reported to CMS, 2019-2025
51 companies · $4,811 in 2025
The $4,811 reported for 2025 was more than what 87% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,418 · 2020: $4,602 · 2021: $4,434 · 2022: $3,890 · 2023: $1,278 · 2024: $2,611 · 2025: $4,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,325 · Honoraria: $1,031 · Travel and Lodging: $290 · Education: $53.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,324.77 |
| Honoraria | $1,031.25 |
| Travel and Lodging | $289.61 |
| Education | $53.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,814.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $2,788.98 | 2019-2025 | |
| Medtronic, INC. | $2,680.37 | 2021-2025 | Minimed 780g |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,474.55 | 2019-2022 | |
| Amgen INC. | $1,959.26 | 2019-2025 | Tepezza, Evenity |
| Recordati_rare_diseases_inc. | $1,710.62 | 2021-2025 | Isturisa, Signifor Lar |
| Corcept Therapeutics | $1,606.01 | 2019-2025 | Korlym |
| Medtronic Minimed, INC. | $1,268.00 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,174.84 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,051.63 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,007.65 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $959.93 | 2019-2025 | Mounjaro, Jardiance, Humulin |
| Amarin Pharma, INC. | $576.26 | 2019-2022 | |
| Beta Bionics, INC. | $373.72 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbott Laboratories | $365.33 | 2019-2025 | Freestyle Libre 2 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Talal Faris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.